# FDA Inspection 1029812 - Thrombolysis in Myocardial Infarction (TIMI) Study Group - October 12, 2017

Source: https://www.keypedia.com/records/fda_inspections/thrombolysis-in-myocardial-infarction-timi-study-group/8b28f4f4-962d-4eb0-a1d2-559d2dd86144
Source feed: FDA_Inspections

> FDA Inspection 1029812 for Thrombolysis in Myocardial Infarction (TIMI) Study Group on October 12, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1029812
- Company Name: Thrombolysis in Myocardial Infarction (TIMI) Study Group
- Inspection Date: 2017-10-12
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 945856 - 2015-08-25](https://www.keypedia.com/records/fda_inspections/thrombolysis-in-myocardial-infarction-timi-study-group/4cdefdc0-b839-4568-bf73-f62dcb861936)

Company: https://www.keypedia.com/companies/thrombolysis-in-myocardial-infarction-timi-study-group/ccef5643-4dd8-495d-b5ca-736dd6e91f62

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c